Cell-penetrating peptides as a gateway for nanocarrier-mediated glioblastoma therapy
Precision Medication · 2026-06 · 3 (2) · 100093
DOI: 10.1016/j.prmedi.2026.100093 ↗Kurz gefasst
Fachartikel in der Zeitschrift Precision Medication, 2026-06. Verfasst von Aditi Sonone und 5 weiteren Autor:innen. Die Arbeit nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Sonone, A., Thakur, M., Trivedi, S., Patel, S., Kawadkar, M., & Wadher, K. (2026). Cell-penetrating peptides as a gateway for nanocarrier-mediated glioblastoma therapy. Precision Medication, 3(2), 100093. https://doi.org/10.1016/j.prmedi.2026.100093
Vancouver
Sonone A, Thakur M, Trivedi S, Patel S, Kawadkar M, Wadher K. Cell-penetrating peptides as a gateway for nanocarrier-mediated glioblastoma therapy. Precision Medication. 2026;3(2):100093. doi:10.1016/j.prmedi.2026.100093
BibTeX
@article{Sonone2026,
author = {Sonone, Aditi and Thakur, Mansi and Trivedi, Sagar and Patel, Sapna and Kawadkar, Manisha and Wadher, Kamlesh},
title = {Cell-penetrating peptides as a gateway for nanocarrier-mediated glioblastoma therapy},
journal = {Precision Medication},
year = {2026},
volume = {3},
number = {2},
pages = {100093},
doi = {10.1016/j.prmedi.2026.100093}
}
EUVIMED